APPLE Academy is a prestigious educational initiative by the Asia-Pacific Primary Liver Cancer Expert Association (APPLE), designed to nurture the next generation of liver cancer experts.
This intensive program brings together young clinicians and researchers from across the Asia-Pacific region for in-depth learning, case discussions, and networking with world-renowned faculty in the field of liver cancer.
With strong support from leading industry partners, APPLE Academy offers a unique platform to share real-world clinical insights, explore the latest advancements, and build long-lasting professional collaborations.

Friday, July 11, 2025

09:20-09:30

Opening

Pierce Chow (Singapore)

SESSION 1: CHANGES IN THE LANDSCAPE OF HCC

09:30-09:55

Changing Etiology and Epidemiology of HCC in Asia

Wonseok Kang (Seoul)

09:55-10:20

Real World Data on the Management of HCC in the Asia-Pacific

Kaina Chen (Singapore)

10:20-10:45

Adaptation of Practice Guidelines: When East Meets West

Do Young Kim (Seoul)

10:45-11:00

Q&A

11:00-11:15

Break

SESSION 2: APPLE ACADEMY: THE ROADS BEFORE US

11:15-11:50

Promoting the Next-Generation Asian Liver Cancer Experts to the Global Arena

Pierce Chow (Singapore) & Chiun Hsu (Taipei)

11:50-12:50

Luncheon Symposium [by Eisai]

SESSION 3: UNMET CLINICAL NEEDS IN HCC AND CURRENT CLINICAL RESEARCH DIRECTIONS

12:50-13:15

Challenges of Biomarker Development: Pathologist's View

Young Nyun Park (Seoul)

13:15-13:40

Challenges of Biomarker Development: Clinician's View

Han Chong Toh (Singapore)

13:40-14:05

Advanced HCC: Novel Approaches beyond IMbrave150, HIMALAYA, and Checkmate 9DW

Yi-Hsiang Huang (Taipei)

14:05-14:30

Integrating Systemic and Liver-Directed Therapy: Current Evidence and Future Development

Stephen L Chan (Hong Kong)

14:30-14:45

Q&A

14:45-15:00

Break

SESSION 4: FROM APPLE ACADEMY INTO THE FUTURE

15:00-15:25

How to Promote Investigator-Initiated Trials for HCC in the Asia-Pacific Region?

Ryosuke Tateishi (Tokyo)

15:25-15:50

Translational Research of New Drug Development for HCC: Scientist's View

Alfred Cheng (Hong Kong)

15:50-16:25

Panel Discussion: The APPLE Association as a Platform for Future International Research Collaboration

Closing Remarks

16:25-16:30

Closing Remark

Jian Zhou (Shanghai)

The APPLE Academy receives sponsorship from Eisai.